Advertisement

Picture BIO Deutschland Dt Biotechnologietage DBT 2016 Leipzig April 600x60px
All >

Deals > Germany

Find below collaborations, license and distribution agreements, grants, investments and loan agreements from Germany or involving German organisations.

Total search results: 6817 | Ordered by Date (descending)
next pagenext page 1 2 3 4 ... 67 68 69  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Neuway Pharma–Wellington Partners: investment, 201510 financing round Series A Extension totalling €3.15m incl €2m from Wellington Partners 2015-10-22
Beyond Batten Disease Foundation–Evotec: drug discovery services, 201510–201712 supply service €na assay developm + use for drug discovery 2015-10-20
Noxxon–SEVERAL: investment, 201510– intention to launch IPO of new shares at Euronext Amsterdam + Paris 2015-10-20
Probiodrug–BIO (US): investor conference, 201510 supply service Probiodrug presents at BIO Investor Forum in San Francisco 2015-10-20
Sigma-Aldrich–Honeywell: research chemicals, 201510–201512 acquisition of Sigma-Aldrich research chemicals business by Honewell 2015-10-20
Zellkraftwerk–Helmholtz: investment, 201510 Ascenion acquires equity position under license agreem with MHH for Swith-Antibodies technology 2015-10-20
Zellkraftwerk–MHH: Switch-Antibodies technology, 201510– license ww excl to Zellkraftwerk GmbH from MHH 2015-10-20
Univ Münster–Thermo Fisher: mass spectrometer, 201510 supply Q Exactive GC hybrid quadrupole-Orbitrap GC-MS/MS system to MEET Battery Research Center 2015-10-19
Curetis–SEVERAL: investment, 201510–201511 IPO €40m+€4.3m w 4m+431k new shares at €10/share at Euronext Amsterdam + Brussels 2015-10-14
Luxendo–EMBL: investment, 201510 financing round Series A totalling €6m co-led by EMBL Ventuers + LSP 2015-10-14
Luxendo–Life Sciences Partners: investment, 201510 financing round Series A totalling €6m co-led by EMBL Ventuers + LSP 2015-10-14
Luxendo–SEVERAL: investment, 201510 financing round Series A €6m co-led by EMBL Ventuers + LSP 2015-10-14
Zymeworks–Minapharm: GlymaxX technology, 201510– supply service cell line development for bispecific antibody production applying GlymaxX by ProBioGen 2015-10-14
Boehringer–Philogen: cancer immunotherapy, 201510– collab novel therapeutic concepts for treating AML 2015-10-12
Affimed–OTHER: investment, 201510 investment €19.2m purchase of 3.3m shares by existing shareholder 2015-10-09
NEO New Oncology–Akampion: public relations, 201510 service existent by Akampion 2015-10-09
NEO New Oncology–SEVERAL: investment, 201510 financing round €5m 2015-10-09
Glycotope–Octapharma: investment, 201510 acquisition of new shares by Octapharma as part of excl license deal 2015-10-08
Octapharma–Glycotope: protein expression technology, 201510– license ww excl to human coagulation factors based on GEX technology 2015-10-08
Merck (US)–Proteros: drug discovery services, 201510– collab €na upfront + research funding + $126m milestones + royalties r+d small mol cancer drug 2015-10-07
Nestlé–Lipotype: lipidomics research, 201510 collab existent use of Lipotype technology for lipid analysis in nutritional research NIHS 2015-10-07
Probiodrug–Rentschler: biological contract manufacturing, 201510– process developm + production of PBD-C06 for pre-clinical + clinical studies 2015-10-07
EMBL–IBM: software tools, 201510– supply EMBL deploys Aspera s/w for fast + reliable data transfer 2015-10-05
Affimed–Aeris Capital: investment, 201510 investment $21.8m for 3.3m shares by existing investor Aeris Capital 2015-10-01
Opti-Lab–Omnilab (DE): investment, 201510 acqu of additonal shares resulting in majority for Omnilab w sole minority owner now Sebastian Haselhun 2015-10-01
Tizona Therapeutics–Minapharm: GlymaxX technology, 201510– license + contract manufacturing agreem for use of GlymaxX for cancer antibody ProBioGen AG 2015-10-01
Infinity Pharmaceuticals–Max Planck: drug discovery services, 201509– collab in cancer using LDC network with MPG + Helmholtz 2015-09-29
Beijing Clear Biotech–Curetis: Unyvero platform, 201509– distribution excl in Greater China of system + 2 cartridges by BCB 2015-09-25
Medigene–Baader Bank: investor conference, 201509 supply service Medigene presents at Baader Investment Conference 2015 in Munich 2015-09-22
Zedira–Cardiff Univ: drug discovery, 201509– collab research role of transglutaminase 6 in disease pathway of cerebellar ataxia 2015-09-22
Qiagen–PathoFinder: molecular diagnostics, –201509 collab developm + production of RespiFast RG Panel for Rotor-Gene Q MDx instrument 2015-09-21
Biametrics–SEVERAL: investment, 201509 financing round Series A €3.1m from LBBW Venture + MBG BW + KfW 2015-09-18
French Myopathy Association–Cevec: cell line technology, 201509– license €na to use CAP GT technology for lentivirus cell line developm to Généthon 2015-09-17
Nestlé–Lipid Therapeutics: gastrointestinal drug, 201609– license excl to develop + market LT-02 ww excl Europe + Australia to Nestlé Health Science 2015-09-16
IAVI–CureVac: mRNA technology, 201509– collab using RNActive technology to deliver HIV immunogens for developm of AIDS vaccines 2015-09-10
Lophius–SEVERAL: investment, 201509 financing round incl VRD GmbH + S-Refit + Wolf Biotech + Bayern Kapital + HTGF 2015-09-10
Venneos–High-Tech Gründerfonds: investment, 201509 seed financing round totalling €1m from HTGF + Max Planck + business angels + family offices 2015-09-10
Venneos–Max Planck: investment, 201509 seed financing round totalling €1m from HTGF + Max Planck + business angels + family offices 2015-09-10
Venneos–SEVERAL: investment, 201509 seed financing round €1m from HTGF + Max Planck + business angels + family offices 2015-09-10
Lophius–High-Tech Gründerfonds: investment, 201509 financing round incl VRD GmbH + S-Refit + Wolf Biotech + Bayern Kapital + HTGF 2015-09-09
Lumora–Erba Diagnostics Mannheim: investment, 201509 acquisition of Lumora Ltd renamed Erba Molecular Ltd 2015-09-07
Boehringer–Vectron Biosolutions: gene expression technology, 201509– license non-excl to Vectron technology for use w BI e. coli production system 2015-09-01
Labfolder–SEVERAL: investment, 201509 financing round € 7-digit led by Charité Biomedical Fund (CBF-1) 2015-09-01
Pfizer–Evotec: drug discovery services, 201509– collab + license agreem 4 years to develop anti-fibrotics 2015-09-01
GeneWorks–Genetrix (ES): genomic reagents, 201508– distribution non-excl Sygnis TruePrime + SunScript RT products in Australia 2015-08-25
MorphoSys–Immatics: cancer immunotherapy, 201508– collab strategic alliance r+d using Xpresident + Ylanthio platforms 2015-08-25
Osthus–Dotmatics: bioinformatics, 201508– collab combined services + product offering for RnD IT for life sciences 2015-08-24
Freudenberg–CMS: legal services, 201508 legal advice by CMS Hasche Sigle on acquisition of Hemoteq AG by Freudenberg Medical Europe GmbH 2015-08-21
Hemoteq–Freudenberg: investment, 201508 acquisition of 74.9% majority share in Hemoteq AG by Freudenberg Medical Europe GmbH 2015-08-21
Nanodigmbio–Genetrix (ES): genomic reagents, 201508– distribution of Sygnis TruePrime + SunScript RT products in China by Nanodigmbio 2015-08-20
EBS Technologies–Earlybird: investment, 201508 financing round totalling €1.1m led by returning investors Earlybird + HTGF 2015-08-19
EBS Technologies–High-Tech Gründerfonds: investment, 201508 financing round totalling €1.1m led by returning investors Earlybird + HTGF 2015-08-19
EBS Technologies–PERSON: investment, 201508 financing round €1.1m led by Earlybird + HTGF plus 3 private investors incl R Christine 2015-08-19
EBS Technologies–SEVERAL: investment, 201508 financing round €1.1m led by Earlybird + HTGF plus 3 private investors incl R Christine 2015-08-19
Sanofi–Evotec: cancer immunotherapy, 201508– collab r+d small-molecules of Evotec + Apeiron + Sanofi 2015-08-10
JenaValve–SEVERAL: investment, 201508 financing round $26.5m including Gimv 2015-08-07
Nomad Bioscience–Denka: investment, 201508–201708 acquisition up to €75m of 51% share in Icon Genetics GmbH + after 2y acquiring rest by Denka 2015-08-07
Sanofi–Evotec: drug discovery, 201508– collab research beta cell replacement therapy for diabetes 2015-08-07
Deutsche Biotech Innovativ–Kirchhoff Consult: public relations, 201508 service existent by Kirchhoff Consult AG 2015-08-06
MorphoSys–G7 Therapeutics: therapeutic antibodies, 201508– collab to develop therap ABs targeting GPCRs 2015-08-04
AdvanceCor–SEVERAL: investment, 201508 2nd financing round €2.2m led by MIG AG inkl Bayern Kapital + Bio-M + HTGF + KfW Bank + founders 2015-08-01
Deutsche Biotech Innovativ–SEVERAL: investment, 201508–201511 capital increase €1.6m 49k new shares €33.5/share out of 596.4k shares on public offer 2015-08-01
DSM–Evonik: animal feed, 201507– collab developm algae-based production of omega-3 fatty acids for animal nutrition 2015-07-29
Apogenix–R-Biopharm: cancer companion diagnostics, 201507– collab developm CDx for Apogenix’ CD95 ligand inhibitor APG101 2015-07-28
Boehringer–Hanmi: kinase inhibitor, 201507– license to HM61713 ww excl KR + CN + HK with $50m upfront + $680m milestones + royalties 2015-07-28
Hikma–Boehringer: investment, 201507– acquisition 40m new shares £940m representing 16.71% as part of sale of Roxane by BI to Hikma 2015-07-28
MRC Technology–Univ Göttingen: therapeutic antibodies, 201507– collab developm ABs targeting amyloid beta 4-x for Alzheimer’s Disease 2015-07-28
Leon-Nanodrugs–Albany Private Equity: investment, 201507 financing round Series A 1st closing totalling €18.5m incl Albany Private Equity Holding 2015-07-27
Leon-Nanodrugs–CD-Venture: investment, 201507 financing round Series A 1st closing totalling €18.5m incl CD-Venture 2015-07-27
Leon-Nanodrugs–LifeCare Partners: investment, 201507 financing round Series A 1st closing totalling €18.5m incl LifeCare Partners 2015-07-27
Leon-Nanodrugs–MJR PharmJet: nanoparticle drug delivery technology, 201507 collab existent 2015-07-27
Leon-Nanodrugs–OTHER: investment, 201507 financing round Series A 1st closing totalling €18.5m incl non-disclosed German Family Office 2015-07-27
Leon-Nanodrugs–SEVERAL: investment, 201507 financing round Series A 1st closing €18.5m led by TVM Capital Life Science 2015-07-27
Leon-Nanodrugs–Signet Healthcare Partners: investment, 201507 financing round Series A 1st closing totalling €18.5m incl Signet 2015-07-27
Leon-Nanodrugs–TVM: investment, 201507 financing round Series A 1st closing totalling €18.5m led by TVM Capital Life Science 2015-07-27
Medigene–QVT: investment, 201507 QVT owns 15.6% of Medigene shares after capital increase 2015-07-25
Poxel–MacDougall Biomedical Communications: public relations, 201507 service existent IR + PR in EU + US 2015-07-24
Scienion–Anteo Technologies: protein microarray technology, 201507– collab developm protein microarray consumables using Mix&Go technology 2015-07-24
Merck (DE)–BioMed X: pharma research, 201507– collab Merck Serono extension funding two cancer research groups at BioMed X 2015-07-23
Cevec–SEVERAL: investment, 201507 financing round €4.5m from Peppermint + Creathor Venture + NRW.Bank + Investtodate et al 2015-07-22
Leukocare–LifeCare Partners: investment, 201507 financing round led by LifeCare Partners + incl new + existing investors 2015-07-22
Leukocare–SEVERAL: investment, 201507 financing round led by LifeCare Partners + incl new + existing investors 2015-07-22
Merck (DE)–Genedata: bioinformatics, 201507– supply Merck Serono implements Genedata Biologics as workflow platform for biopharma RnD 2015-07-22
Medigene–Aviva: investment, 201507 acquisition 1.97m shares by Aviva plc representing 10.01% of Medigene shares after capital increase 2015-07-20
Canbridge Life Sciences–Apogenix: cancer drug, 201507– license developm + commercialisation of APG101 in Greater China 2015-07-15
Apceth–Univ Cologne: T-cell immunotherapy, 201507– collab with CMMC use of MSCs for local activatio of CAR T-cells within tumours 2015-07-10
Insilico Biotechnology–SEVERAL: investment, 201507 capital increase 2015-07-10
JeNaCell–Evonik: investment, 201507 financing round Series A incl new investor Evonik Industries 2015-07-09
JeNaCell–High-Tech Gründerfonds: investment, 201507 financing round Series A incl existing investor HTGF 2015-07-09
JeNaCell–SEVERAL: investment, 201507 financing round Series A from Evonik + bm-t + Sparkasse Jena + HTGF + STIFT 2015-07-09
Qiagen–Seegene: molecular diagnostics, 201507– collab ww marketing validated multi-plexed Seegene PCR tests for QIAsymphony RGQ MDx system 2015-07-08
Cellca–Sartorius: investment, 201507 acquisition of Cellca GmbH by Sartorius Stedim Biotech 2015-07-02
Neovacs–MC Services: public relations, 201507 service existent by MC Services IR in Germany 2015-07-02
Biotest–Cevec: rec protein production technology, 201507– license to CAP Go technology to Biotest AG 2015-07-01
GNA Biosolutions–Instinctif Partners: public relations, 201507 service existent by Instinctif Partners 2015-07-01
GNA Biosoutions–SEVERAL: investment, 201507 financing round Series B €6m led by new investor Robert Bosch Venture Capital GmbH 2015-07-01
Qiagen–Zörgiebel Group: molecular diagnostics, 201506– collab founding joint venture Biotye Innovation GmbH to develop MDx companion diagnostics 2015-06-26
BioNTech–Siemens: cancer vaccine, 201506– collab developm + construction automated production facility for IVAC products Siemens Process Automation 2015-06-25
BioNTech–Strüngmann Group: investment, 201506 existent Strüngman family office is majority shareholder of BioNTech AG 2015-06-25
Ankasa Regenerative–Heraeus: investment, 201506 financing round Series A 1st tranche totalling $8.5m of $17m Series A incl Heraeus Medical 2015-06-23
next pagenext page 1 2 3 4 ... 67 68 69  next pagenext page



Advertisement

Picture Fairtec GmbH Worldwide Event Solutions 600x60px

To subscribe to our free, monthly newsletter for the life sciences in German-speaking Europe (DE, AT & CH), please send an e-mail to info@iito.de and simply fill the subject line with the word »LSG newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture [iito] Roadshow Season Spring 2016 JPMorgan Healthcare 2017 600x560px

» top

Advertisements

Picture [iito] Roadshow Spring 2016 Offer 120x180px Picture EBD Group ChinaBio Partnering Forum 2016 CBPF Suzhou May 120x180px Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px